Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging [NA]

View source ↗

Summary

A university-led trial is investigating how alpha-synuclein spreads in Parkinson's disease using blood biomarkers and neuroimaging, with recruitment not yet und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pavia | Conditions: Parkinson's Disease (PD), GBA1 Parkinson Disease | NA | Status: NOT_YET_RECRUITING